Skip to main content
. 2017 Oct 24;26(3):933–945. doi: 10.1007/s00520-017-3914-2

Fig. 2.

Fig. 2

The change of the Quality of Life (QOL) Questionnaire for Cancer Patients Treated with Anticancer Drugs-Breast (QOL-ACD-B) score and the Functional Assessment of Cancer Therapy-Endocrine Symptoms (FACT-ES) subscale score from week 96. a QOL-ACD-B score (total score of items 1 to 18). b FACT-ES subscale score (except for BRM1). N number of patients evaluated, 144 w week 144, 192 w week 192, 240 w week 240, SD standard deviation